Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe
暂无分享,去创建一个
S. Bhatt | S. Flaxman | N. Grassly | Swapnil Mishra | A. Gandy | H. Unwin | T. Mellan | H. Coupland | C. Whittaker | Harrison Zhu | T. Berah | J. Eaton | M. Monod | N. Schmit | L. Cilloni | K. Ainslie | M. Baguelin | A. Boonyasiri | O. Boyd | L. Cattarino | L. Cooper | G. Cuomo-Dannenburg | A. Dighe | I. Dorigatti | R. FitzJohn | K. Gaythorpe | L. Geidelberg | W. Green | T. Hallett | A. Hamlet | W. Hinsley | B. Jeffrey | E. Knock | D. Laydon | P. Nouvellet | K. Parag | I. Siveroni | H. Thompson | R. Verity | E. Volz | C. Walters | Haowei Wang | O. Watson | P. Winskill | P. Walker | A. Ghani | C. Donnelly | S. Riley | L. Okell | M. Vollmer | N. Ferguson | Z. Cucunubá | G. Nedjati-Gilani | S. V. van Elsland | Yuanrong Wang | X. Xi | B. Djaafara | P. Perez-Guzman | Pablo N. Nora Lucia Kylie E. C. Marc Adhiratha Olivia Lo Perez-Guzman Schmit Cilloni Ainslie Bagueli | Tresnia Berah | Lucia Cilloni | Igor Siveroni
[1] Andrew Gelman,et al. Data Analysis Using Regression and Multilevel/Hierarchical Models , 2006 .
[2] Joshua B. Plotkin,et al. Reconstructing influenza incidence by deconvolution of daily mortality time series , 2009, Proceedings of the National Academy of Sciences.
[3] Joel C. Miller,et al. A Note on the Derivation of Epidemic Final Sizes , 2012, Bulletin of mathematical biology.
[4] Jérôme Hugues,et al. Model‐Based Analysis , 2013 .
[5] C. Fraser,et al. A New Framework and Software to Estimate Time-Varying Reproduction Numbers During Epidemics , 2013, American journal of epidemiology.
[6] Dennis Andersson,et al. A retrospective cohort study , 2018 .
[7] S. Lai,et al. Patterns of human social contact and contact with animals in Shanghai, China , 2019, Scientific Reports.
[8] J. Lessler,et al. Estimating the burden of SARS-CoV-2 in France , 2020, Science.
[9] J. Van Wyk,et al. Lessons from a rapid systematic review of early SARS-CoV-2 serosurveys , 2020, medRxiv.
[10] Cécile Viboud,et al. Age profile of susceptibility, mixing, and social distancing shape the dynamics of the novel coronavirus disease 2019 outbreak in China , 2020, medRxiv.
[11] Coronavirus Disease 2019 (COVID-19) Daily Situation Report of the Robert Koch Institute , 2020 .
[12] A. Hyafil,et al. Analysis of the impact of lockdown on the reproduction number of the SARS-Cov-2 in Spain , 2020, Gaceta sanitaria.
[13] Yongsheng Wu,et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study , 2020, The Lancet Infectious Diseases.
[14] Carl A. B. Pearson,et al. Inferring the number of COVID-19 cases from recently reported deaths , 2020, Wellcome open research.
[15] Ruiyun Li,et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2) , 2020, Science.
[16] C. Whittaker,et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis , 2020, The Lancet Infectious Diseases.
[17] A. Hyafil,et al. Analysis of the impact of lockdown on the evolution Covid-19 epidemics in Spain , 2020, medRxiv.
[18] M. Hernán,et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study , 2020, The Lancet.
[19] Lei Liu,et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019 , 2020, medRxiv.
[20] N. G. Davies,et al. The effect of non-pharmaceutical interventions on COVID-19 cases, deaths and demand for hospital services in the UK: a modelling study , 2020, medRxiv.
[21] N. G. Davies,et al. Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study , 2020, The Lancet Public Health.
[22] Lei Liu,et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019 , 2020, medRxiv.
[23] H. Ullum,et al. Estimation of SARS-CoV-2 Infection Fatality Rate by Real-time Antibody Screening of Blood Donors , 2020, medRxiv.